Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Diabetes can cause a variety of skin disorders, some of which may signal more serious health issues.

High mTORC1 activity slows hair growth and causes it to lose color.

Tip cryotherapy effectively treats idiopathic guttate hypomelanosis with minimal side effects.

Use antimalarials like hydroxychloroquine for cutaneous lupus, avoid herbal supplements, and focus on lifestyle changes like sun protection.

Covers common skin issues in kids, their diagnosis, treatment, and need for specialist care.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

The document concludes that different types of permanent hair loss conditions are related and early treatment is key to preventing further damage.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

BMP signaling is important for skin color, affecting melanin production, pigment spread, and cell movement.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Chitosan-coated nanoparticles improve skin delivery of hair loss treatments with fewer side effects.

Clascoterone cream effectively reduces acne severity and is safe for patients 12 and older.

New treatments targeting insulin, blood flow, and inflammation could improve hormone-related hair conditions with fewer side effects.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

JAK inhibitors show promise for treating various skin diseases.

Clascoterone is safe for the heart, even at high doses.

Laser and minoxidil combo promotes better hair growth than minoxidil alone, safely.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.